Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity.
about
Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.PEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia.Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?The therapeutic potential of IGF-I in skeletal muscle repair.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.Neurotrophic and Neuroregenerative Effects of GH/IGF1.Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALS.
P2860
Q30659873-1BB8EFB8-37F4-4E9F-B497-0E2AD2594CB6Q33670730-E0EE19EE-E1DB-453F-B55C-2923BEA6E60AQ36361099-48D11F3C-CAAD-4CB0-847A-C1BD35C2D696Q37068201-5570CA05-3D7D-47EB-BB95-CE025670FA57Q38573829-D18F3C6E-0B64-42CE-A7FA-52156C70107CQ39219980-4C3DED0B-66FF-4B11-8A45-A2DBB7CCFFD4Q47152037-B4A6D17A-7242-42A5-89E8-A6E315D31DA9Q48480002-E5DB436C-A44C-4C99-97B1-F54F1C703878
P2860
Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Functional improvement in mous ...... t depends on disease severity.
@en
Functional improvement in mous ...... t depends on disease severity.
@nl
type
label
Functional improvement in mous ...... t depends on disease severity.
@en
Functional improvement in mous ...... t depends on disease severity.
@nl
prefLabel
Functional improvement in mous ...... t depends on disease severity.
@en
Functional improvement in mous ...... t depends on disease severity.
@nl
P2093
P2860
P1476
Functional improvement in mous ...... t depends on disease severity.
@en
P2093
Bettina Holtmann
Friedrich Metzger
Heidemarie Kletzl
Mark R Nilges
Stefanie Saenger
Susanne Ostrowitzki
Susanne Schroeder
Taleen Hanania
Will Spooren
P2860
P304
P356
10.3109/17482968.2012.679944
P577
2012-08-07T00:00:00Z